Company Information & Drug Savings for Vivus LLC Medications

VIVUS LLC is a specialty biopharmaceutical company headquartered in Campbell, California, focused on the development and commercialisation of innovative therapies for serious and life-limiting conditions. Founded in 1991 and now a subsidiary of Icahn Enterprises LP, VIVUS markets three FDA-approved products in the US: Qsymia® (phentermine/topiramate extended-release) for chronic weight management; PANCREAZE® (pancrelipase) for exocrine pancreatic insufficiency due to cystic fibrosis and other conditions; and STENDRA® (avanafil) for erectile dysfunction. The company combines clinical development expertise with a dedicated specialty sales force to address unmet medical needs across obesity, endocrinology, and urology.

Vivus LLC

How to Contact Vivus LLC

Medical Disclaimer

NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current. However, the knowledge and experience of a qualified healthcare professional should always be sought after instead of using the information on this page. Before taking any drug, you should always speak to your doctor or another qualified healthcare provider.

The information provided here about medications is subject to change and is not meant to include all uses, precautions, warnings, directions, drug interactions, allergic reactions, or negative effects. The absence of warnings or other information for a particular medication does not imply that the medication or medication combination is appropriate for all patients or for all possible purposes.

Experienced a Side Effect?

Report to

👉
Yellowcard logo
(UK)
👉
Medwatch logo
(US)
NowPatient - Report Side Effects to Yellow Card or MedWatch